Actively Recruiting
Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
Led by Lund University · Updated on 2026-02-20
48
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to develop a new internet-delivered cognitive behavioral therapy (ICBT) intervention for youths with anxiety disorders based on the best current knowledge about effective cognitive behavioral therapy for the target group, refine the intervention in collaboration with patient and public representatives, and conduct a preliminary evaluation of the treatment effects in an open clinical trial. The primary objective of the study is: 1\. To evaluate the preliminary efficacy of a newly developed ICBT intervention for children and adolescents with anxiety disorders in reducing anxiety severity, as measured by the Pediatric Anxiety Rating Scale (PARS). Secondary objectives of the study are: 1. To examine the preliminary efficacy (PARS) of the ICBT intervention at 3 months post-treatment. 2. To examine how youths with anxiety disorders, their caregivers, therapists, and healthcare leadership experience the ICBT intervention. 3. To examine factors (e.g., age, type of anxiety disorder, presence of depressive symptoms, experiences of ICBT) that predict treatment outcome. 4. To examine how the ICBT intervention can be improved (e.g., treatment content and technical delivery) for future use. Participants will: * Undergo ICBT treatment for anxiety disorders during 12 weeks * Complete questionnaires at multiple time points throughout the study * Participate in follow-ups post-treatment and 3 months post-treatment * A selection of participants will also be invited to focus group interviews with the aim to generate ideas on how the intervention may be improved for future use
CONDITIONS
Official Title
Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 8 and less than 18 years confirmed by child/caregiver and medical records
- Diagnosed with a principal DSM-5-TR anxiety disorder including specific phobia, separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, panic disorder, or agoraphobia confirmed by DIAMOND-KID interview
- Child and caregiver able to read, write, and communicate in Swedish
- Caregiver available to support the child during treatment
- Access to a smartphone, tablet, or computer with internet
You will not qualify if you...
- Principal anxiety disorder is blood-injection-injury phobia
- Established or suspected intellectual disability confirmed by caregiver or special education attendance
- Other mental disorders needing more immediate treatment such as psychotic disorders, bipolar disorder, anorexia nervosa, or substance use disorders
- Social, family, or educational difficulties requiring more urgent management than anxiety
- Immediate risk to self or others requiring urgent attention, including acute suicidality
- Previous cognitive behavioral therapy for anxiety with five or more sessions within the last 12 months
- Ongoing psychological treatment for anxiety
- Starting or changing psychotropic medication for anxiety within 8 weeks prior to assessment
- Participation in user involvement sessions for this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Barn- och ungdomshälsan, Länssjukhuset
Kalmar, Region Kalmar Län, Sweden, 391 85
Actively Recruiting
Research Team
P
Per Andrén, PhD
CONTACT
E
Eva Serlachius, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here